- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Alatrofloxacin is an antibiotic used to treat a variety of bacterial infections. It belongs to the fluoroquinolone class of antibiotics, which are used to treat a wide range of bacterial infections. Alatrofloxacin is used to treat infections of the respiratory tract, urinary tract, skin, and soft tissue. It is also used to treat certain types of pneumonia, sinusitis, and bronchitis. Alatrofloxacin is generally well tolerated, with few side effects.
The market for Alatrofloxacin is driven by the increasing prevalence of bacterial infections, as well as the growing demand for antibiotics. The rising prevalence of antibiotic-resistant bacteria is also driving the market for Alatrofloxacin. The increasing demand for generic drugs is also contributing to the growth of the Alatrofloxacin market.
Some of the major companies in the Alatrofloxacin market include Pfizer, Merck, GlaxoSmithKline, Sanofi, Novartis, and AstraZeneca. Show Less Read more